These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2615338)

  • 1. Impact of adulterants on RIA analysis of urine for drugs of abuse.
    Cody JT; Schwarzhoff RH
    J Anal Toxicol; 1989; 13(5):277-84. PubMed ID: 2615338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening postmortem blood and tissues for nine classes [correction of cases] of drugs of abuse using automated microplate immunoassay.
    Moore KA; Werner C; Zannelli RM; Levine B; Smith ML
    Forensic Sci Int; 1999 Dec; 106(2):93-102. PubMed ID: 10664895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectability of phencyclidine and 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in adulterated urine by radioimmunoassay and fluorescence polarization immunoassay.
    Bronner W; Nyman P; von Minden D
    J Anal Toxicol; 1990; 14(6):368-71. PubMed ID: 1964989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adulterants causing false negatives in illicit drug testing.
    Mikkelsen SL; Ash KO
    Clin Chem; 1988 Nov; 34(11):2333-6. PubMed ID: 3052928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay screening and GC/MS confirmation of whole blood samples for drugs of abuse.
    Spiehler VR; Sedgwick P
    J Anal Toxicol; 1985; 9(2):63-6. PubMed ID: 3990249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
    Moody DE; Rittenhouse LF; Monti KM
    J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
    Matriciani B; Huppertz B; Keller R; Weiskirchen R
    Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips.
    Olivieri B; Marić M; Bridge C
    Drug Test Anal; 2018 Sep; 10(9):1383-1393. PubMed ID: 29749024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunoassays for cannabinoids in urine.
    Irving J; Leeb B; Foltz RL; Cook CE; Bursey JT; Willette RE
    J Anal Toxicol; 1984; 8(4):192-6. PubMed ID: 6471820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Coat-A-Count 125I fentanyl RIA: comparison of 125I RIA and GC/MS-SIM for quantification of fentanyl in case urine specimens.
    Watts VW; Caplan YH
    J Anal Toxicol; 1990; 14(5):266-72. PubMed ID: 2263059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of EMIT and RIA high volume test procedures for THC metabolites in urine utilizing GC/MS confirmation.
    Abercrombie ML; Jewell JS
    J Anal Toxicol; 1986; 10(5):178-80. PubMed ID: 3022068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
    Dasgupta A; Wahed A; Wells A
    Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.